In brief: Burns joins Progen; Cryptome appoints CSO
Monday, 23 August, 2004
Progen Industries (ASX: PGL, NASDAQ: PGLAF), announced today it had appointed former Bresagen chief financial officer and company secretary, Linton Burns, as CFO and company secretary.
Burns succeeds Milton McColl, has been Progen's CFO since late 2001.
And Melbourne-based Cryptome Pharmaceuticals (ASX: CRP) has appointed Dr Leodevico Ilag as chief scientific officer. Dr Ilag is the co-founder, former managing director and current chief technology officer of Munich proteomics company Xerion Pharmaceuticals. He is due to join Cryptome in September 2004.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
